Press release
Global Alzheimer's Therapeutics Market to Reach USD 13 billion by 2031: Growth Opportunities, Emerging Innovations, and Competitive Dynamics
๐๐ฅ๐ณ๐ก๐๐ข๐ฆ๐๐ซ'๐ฌ ๐๐ก๐๐ซ๐๐ฉ๐๐ฎ๐ญ๐ข๐๐ฌ ๐๐๐ซ๐ค๐๐ญ
๐๐ก๐๐ญ ๐๐ซ๐ ๐ญ๐ก๐ ๐๐ซ๐ข๐ฏ๐ข๐ง๐ ๐๐๐๐ญ๐จ๐ซ๐ฌ ๐๐จ๐ซ ๐ญ๐ก๐ ๐๐ฅ๐ณ๐ก๐๐ข๐ฆ๐๐ซ'๐ฌ ๐๐ก๐๐ซ๐๐ฉ๐๐ฎ๐ญ๐ข๐๐ฌ ๐๐๐ซ๐ค๐๐ญ?
Increase in the prevalence of Alzheimer's disease across both the developed and developing countries drives the growth of the Alzheimer's therapeutics market. Based on drug class, the cholinesterase inhibitors segment held the major share in 2021. By region, on the other hand, Asia-Pacific would display the fastest CAGR by 2031.
๐๐๐ญ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐๐ ๐๐๐ฉ๐จ๐ซ๐ญ ๐ฐ๐ข๐ญ๐ก ๐๐ซ๐๐ฉ๐ก๐ฌ ๐๐ง๐ ๐ ๐ข๐ ๐ฎ๐ซ๐๐ฌ ๐๐๐ซ๐: https://www.alliedmarketresearch.com/request-sample/10900
๐๐ฆ๐ฉ๐๐๐ญ ๐จ๐ ๐๐จ๐ฏ๐ข๐-๐๐ ๐จ๐ง ๐ญ๐ก๐ ๐๐ฅ๐ณ๐ก๐๐ข๐ฆ๐๐ซ'๐ฌ ๐๐ก๐๐ซ๐๐ฉ๐๐ฎ๐ญ๐ข๐๐ฌ ๐๐๐ซ๐ค๐๐ญ-
โข Patients who suffered from Alzheimer's disease were more vulnerable to be infected by coronavirus.
โข Rise in number of Covid-19 infection in patients with Alzheimer's disease led to increase in demand for Alzheimer's therapeutics during the pandemic period.
๐๐จ๐ฉ ๐๐๐ฒ ๐๐ฅ๐๐ฒ๐๐ซ๐ฌ ๐จ๐ ๐๐ฅ๐ณ๐ก๐๐ข๐ฆ๐๐ซ'๐ฌ ๐๐ก๐๐ซ๐๐ฉ๐๐ฎ๐ญ๐ข๐๐ฌ ๐๐๐ซ๐ค๐๐ญ
โข AbbVie Inc.
โข Biogen Inc.
โข Merck & Co. Inc.
โข Novartis AG
โข Eisai Co. Ltd.
โข Lundbeck A/S
โข Daiichi Sankyo Company Ltd.
โข Teva Pharmaceuticals Industries Ltd.
โข Eli Lilly and Company
These market players have embraced several strategies including partnership, expansion, collaboration, joint ventures, and others to highlight their prowess in the industry. The report is helpful in formulating the business performance, product portfolio, operating segments, and developments by the top players.
๐๐ฅ๐จ๐๐๐ฅ ๐๐ฅ๐ณ๐ก๐๐ข๐ฆ๐๐ซ'๐ฌ ๐๐ก๐๐ซ๐๐ฉ๐๐ฎ๐ญ๐ข๐๐ฌ ๐๐๐ซ๐ค๐๐ญ ๐ฌ๐๐ ๐ฆ๐๐ง๐ญ๐๐ญ๐ข๐จ๐ง
The global Alzheimer's therapeutics market is analyzed across drug class, distribution channel, and region. The report takes in an exhaustive analysis of segments and their sub-segments with the help of tabular and graphical representation. Investors and market players can benefit from the breakdown and devise stratagems based on the highest revenue-generating and fastest-growing segments stated in the report.
Based on drug class, the cholinesterase inhibitors segment garnered more than half of the total market revenue in 2021, and is expected to dominate by 2031. The others segment, simultaneously, would manifest the fastest CAGR of 22.0% throughout the forecast period. The N-Methyl-D-Aspartate (NMDA) receptor antagonist segment is also assessed in the report.
By distribution channel, the drug store and retail pharmacy segment held nearly three-fifths of the global Alzheimer's therapeutics market in 2021, and is anticipated to retain its dominance by 2031. The online pharmacy segment, on the other hand, would cite the fastest CAGR of 11.9% during the forecast period. The hospital pharmacy segment is also analyzed through the report.
Based on region, the market across North America generated more than two-fifths of the total market revenue in 2021, and is anticipated to retain the lion's share by 2031. The Asia-Pacific region, at the same time, would manifest the fastest CAGR of 10.5% during the forecast period. The other regions studied in the report include LAMEA and Europe.
Purchase the Report: https://www.alliedmarketresearch.com/purchase-enquiry/10900
Our Market Research Solution Provides You Answer to Below Mentioned Question:
Which are the driving factors responsible for the growth of market?
Which are the roadblock factors of this market?
What are the new opportunities, by which market will grow in coming years?
What are the trends of this market?
Which are main factors responsible for new product launch?
How big is the global & regional market in terms of revenue, sales and production?
How far will the market grow in forecast period in terms of revenue, sales and production?
Which region is dominating the global market and what are the market shares of each region in the overall market in 2022?
How will each segment grow over the forecast period and how much revenue will these segments account for in 2030?
Which region has more opportunities?
By Region Outlook
North America
(U.S., Canada, Mexico)
Europe
(Germany, France, UK, Italy, Spain, Rest of Europe)
Asia-Pacific
(Japan, China, India, Rest of Asia-Pacific)
LAMEA
(Brazil, Saudi Arabia, South Africa, Rest of LAMEA)
Contact Details:
David Correa
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
help@alliedmarketresearch.com
About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Alzheimer's Therapeutics Market to Reach USD 13 billion by 2031: Growth Opportunities, Emerging Innovations, and Competitive Dynamics here
News-ID: 3667406 • Views: โฆ
More Releases from Allied Market Research (AMR)
Online Music Streaming Market Demand will reach a value of US$ 24,711.3 million โฆ
The global online music streaming market size is expected to reach $24,711.3 million by 2027 at a CAGR of 12.34% from 2021 to 2027.
Request The Sample PDF Of This Report: https://www.alliedmarketresearch.com/request-sample/11521
Online music streaming is a means of delivering music without downloading any file from the internet. Music is stored on the servers' database and is instantly transferred to the streamer or users' device in realโฆ
Low-E Glass Market Growth Trends: Global Analysis of Leading Players and Busines โฆ
According to the study, the global low-e glass market was valued at $11.9 billion in 2022 and is projected to reach $21.0 billion by 2032, growing at a CAGR of 5.9% from 2023 to 2032.
Download Sample Pages of Research Overview: https://www.alliedmarketresearch.com/request-sample/A15849
Market Drivers and Challenges:
- The growing emphasis on energy efficiency and cost reduction is propelling the demand for low-emissivity (Low-E) glass globally. Despite higher upfront costs compared to traditional glass,โฆ
Sunflower Lecithin Market: Industry Development Challenges, Opportunities & Key โฆ
According to the report, the global sunflower lecithin market was valued at $324.6 million in 2018 and is projected to reach $754.8 million by 2032, growing at a CAGR of 5.7% from 2023 to 2032.
Download Sample Pages of Research Overview: https://www.alliedmarketresearch.com/request-sample/A156654
What is Sunflower Lecithin?
Sunflower lecithin is a natural lipid blend derived from sunflower seeds, either mechanically or chemically, and is prized for its superior emulsifying and stabilizing properties. Composed primarilyโฆ
Bio-Renewable Chemicals Companies Analysis and Developments by 2031
According to the report, the global bio-renewable chemicals market was valued at $2.5 billion in 2021 and is projected to reach $7.4 billion by 2031, registering a CAGR of 11.6% from 2022 to 2031. The study provides an in-depth analysis of market dynamics, emerging trends, key investment areas, value chains, regional insights, and competitive landscapes.
Download Sample Pages of Research Overview: https://www.alliedmarketresearch.com/request-sample/156
Market Drivers, Restraints, and Opportunities
Drivers:
- Technological advancements and innovations inโฆ
More Releases for Alzheimer
Dementia - Alzheimer Disease Market: A Comprehensive Analysis 2030
Dementia and Alzheimer's disease represent significant challenges within the global healthcare sector. These neurological disorders, characterized by progressive cognitive decline, have seen increasing prevalence due to aging populations worldwide. This growing burden has spurred interest in the Dementia - Alzheimer's disease market, encompassing diagnostic tools, treatments, caregiving solutions, and related healthcare services. This article provides an overview of the market, its scope, current trends, and factors driving its expansion.
Data Bridgeโฆ
Alzheimer Disease Treatment Market | Allergan, Amgen, Daiichi Sankyo, Eisai
The global alzheimer disease treatment market report is a comprehensive report that provides a detailed analysis of the current status and future trends of the alzheimer disease treatment market worldwide. This report provides valuable information to industry stakeholders by offering an in-depth perspective on market dynamics, competitive landscape, growth opportunities, and key challenges faced by industry participants.
From the perspective of market dynamics, this report explores the factors driving the growthโฆ
United States Alzheimer Drugs Market Insights Deep Analysis 2023-2031
Cognate Life Sciences introduces a report on "United States Alzheimer Drugs Market 2023" with Market Insights Reports, Introduces systematic details in terms of market valuation, market size, revenue estimation, and geographical spectrum of the business vertical. The study also talks about crucial pockets of the industry such as products or services offered, downstream fields, end using customers, historic data figures regarding revenue and sales, market context and more. It conjointlyโฆ
Global Alzheimer Market, Global Alzheimer Industry, Covid-19 Impact Global Alzhe โฆ
Alzheimer's is a progressive disease that leads to the death of brain cells, resulting in memory loss, behavioral issues, and disruption the thought processes. The Alzheimer disease is considered fatal. Age and heredity are the two main risk factors for developing Alzheimer's disease. Several other preventable risk factors have been associated to the development of this disease, including diet, environment, and overall general health. A combination of risk factors isโฆ
US Alzheimer Drug Pipeline Analysis
In US, the Alzheimer's disease is the 6th leading cause of death overall and among those aged 65 and above, it is the 5th leading cause of death. While the deaths from major diseases, like heart disease have decreased, the death due to Alzheimer's have increased by more than 60% between 2000 and 2012. The total number of patients having Alzheimerโs disease was 5.4 million in 2012. Out of this,โฆ
Global Alzheimer Market Report: 2015 Edition | Now Available at Researchmoz.us
Researchmoz added Most up-to-date research on "Global Alzheimer Market Report: 2015 Edition" to its huge collection of research reports.
Alzheimerโs disease is defined as an advanced neurological disorder that increasingly deprives patients of their memory and ability to carry out daily activities. As it grows in a human brain, individuals are likely to practice difficulties in linguistic, agility and insight along with negative changes in the character and performance such asโฆ
